Arcutis Biotherapeutics Inc
(NASDAQ: ARQT)

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

31.160

+1.200 (+4.01%)
Range 29.373 - 31.390   (6.87%)
Open 29.373
Previous Close 29.960
Bid Price 9.480
Bid Volume 8
Ask Price 9.750
Ask Volume 14
Volume 2,010,392
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis